EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy

Jenny Schunke, Volker Mailänder iD, Katharina Landfester iD, Michael Fichter

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241512174 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jenny Schunke und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: Cancer Vaccines, Nanoparticles, Neoplasms, Drug Carriers. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Finding a long-term cure for tumor patients still represents a major challenge. Immunotherapies offer promising therapy options, since they are designed to specifically prime the immune system against the tumor and modulate the immunosuppressive tumor microenvironment. Using nucleic-acid-based vaccines or cellular vaccines often does not achieve sufficient activation of the immune system in clinical trials. Additionally, the rapid degradation of drugs and their non-specific uptake into tissues and cells as well as their severe side effects pose a challenge. The encapsulation of immunomodulatory molecules into nanocarriers provides the opportunity of protected cargo transport and targeted uptake by antigen-presenting cells. In addition, different immunomodulatory cargos can be co-delivered, which enables versatile stimulation of the immune system, enhances anti-tumor immune responses and improves the toxicity profile of conventional chemotherapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesNanoparticlesNeoplasmsDrug CarriersAdjuvants, ImmunologicHumansAnimalsImmunotherapyTumor MicroenvironmentNanovaccines

Stichwörter der Autor:innen

DC targetingadjuvantsco-deliverynanovaccinestumor-specific antigens

Substanzen

Cancer VaccinesDrug CarriersAdjuvants, ImmunologicNanovaccines

Autor:innen und Institutionen

  • Department of Dermatology, University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Max Planck Insitute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.

ORCID-Profile: Volker Mailänder, Katharina Landfester

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Schunke, J., Mailänder, V., Landfester, K., & Fichter, M. (2023). Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512174

Vancouver

Schunke J, Mailänder V, Landfester K, Fichter M. Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512174

BibTeX
@article{Schunke2023,
  author = {Schunke, Jenny and Mailänder, Volker and Landfester, Katharina and Fichter, Michael},
  title = {Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241512174}
}
Kostenlos starten →